CervoMed Inc. (NASDAQ: CRVO)
$2.2600
+0.0300 ( +3.20% ) 0.3K
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
Market Data
Open
$2.2600
Previous close
$2.2300
Volume
0.3K
Market cap
$18.41M
Day range
$2.1900 - $2.2150
52 week range
$1.8000 - $26.3789
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 30 | Dec 10, 2024 |
8-k | 8K-related | 14 | Dec 03, 2024 |
8-k | 8K-related | 16 | Nov 27, 2024 |
8-k | 8K-related | 18 | Nov 13, 2024 |
10-q | Quarterly Reports | 67 | Nov 12, 2024 |
8-k | 8K-related | 16 | Nov 04, 2024 |
8-k | 8K-related | 16 | Oct 30, 2024 |
8-k | 8K-related | 16 | Oct 16, 2024 |
8-k | 8K-related | 14 | Oct 03, 2024 |
8-k | 8K-related | 16 | Oct 01, 2024 |